RecruitingNCT06829147

A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC)

Development and Validation of a Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma Using Histologic Whole Slide Images and Time-dependent Magnetic Resonance Images


Sponsor

Sun Yat-sen University

Enrollment

500 participants

Start Date

Nov 19, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

(I) AI Model for Diagnosing Lymph Node Metastasis We developed an AI model to help diagnose whether a single lymph node in nasopharyngeal cancer has spread. The model uses MRI images of the lymph node and the area around it. It includes: 1.Automatically identifying the lymph nodes and the primary tumor. 2.Analyzing MRI images of the lymph node and surrounding area. 3.Using MRI scans before and after chemotherapy to track changes in the lymph node. (II) AI Model for Predicting Lymph Node Metastasis We created an AI model that predicts whether a lymph node in a specific area has cancer. This model uses a combination of the primary tumor's pathology and MRI images of both the tumor and lymph node. It also tracks changes in the lymph node over time. The model includes: 1.Analyzing the tumor's pathology to identify specific lymphatic structures. 2.Using MRI scans to predict the likelihood of metastasis in a single lymph node. 3.Examining MRI scans before and after chemotherapy to help determine if the lymph node has metastasized. (III) Verifying and Analyzing the Benefits of the AI Model We are testing the AI model to see how well it works and its potential benefits, including: 1.Checking if the AI can correct past diagnoses of recurrent lymph nodes in nasopharyngeal cancer, which could help guide treatment plans for radiotherapy. 2.Testing the model using biopsy results from head and neck cancer patients to see if it can accurately detect negative lymph nodes. 3.Running clinical trials to test the AI model's safety and effectiveness in guiding radiation treatment for upper neck and single lymph node areas in nasopharyngeal cancer. 4.Analyzing the economic benefits of using the AI model in radiation treatment for nasopharyngeal cancer.


Eligibility

Plain Language Summary

Simplified for easier understanding

This study is developing and validating an artificial intelligence (AI) model that uses MRI and PET/CT scan images to diagnose whether cancer has spread to the lymph nodes in people with nasopharyngeal carcinoma (a type of cancer affecting the back of the nasal cavity and throat). **You may be eligible if...** - You have been diagnosed with nasopharyngeal carcinoma (NPC) confirmed by biopsy - You had MRI and PET/CT scans performed before starting any cancer treatment - Your scans include the required imaging sequences (T1, T2, and contrast-enhanced T1) - You are willing to undergo a lymph node biopsy if MRI and PET/CT results disagree **You may NOT be eligible if...** - Your cancer diagnosis has not been pathologically confirmed - Your imaging was done after cancer treatment had already begun - Your scan images are missing required sequences or are of insufficient quality Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Department of Radiation Oncology, Sun Yat-sen University Cancer Center

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06829147


Related Trials